Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVAH Aveanna Healthcare	$4.87 +3.2%	$5.10	$2.32 ▼ $6.19	$920.84M	2.03	331,239 shs	323,377 shs
CDNA CareDx	$18.95 -0.5%	$17.57	$13.81 ▼ $34.84	$1.06B	2.18	907,962 shs	730,877 shs
DCGO DocGo	$1.69 +6.3%	$1.74	$1.23 ▼ $5.68	$162.15M	0.95	786,195 shs	1.01 million shs
PNTG The Pennant Group	$28.22 +1.6%	$27.69	$21.18 ▼ $37.13	$957.55M	1.52	227,332 shs	195,953 shs

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVAH Aveanna Healthcare	+3.18%	-1.02%	-8.46%	-11.45%	+90.23%
CDNA CareDx	-0.47%	-0.63%	+11.80%	-0.68%	+34.78%
DCGO DocGo	+6.29%	+9.74%	+26.12%	-40.07%	-45.31%
PNTG The Pennant Group	+1.58%	-0.91%	+1.62%	+13.65%	+25.31%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AVAH Aveanna Healthcare	0.713 of 5 stars	1.0	4.0	0.0	1.2	2.5	0.0
CDNA CareDx	4.1648 of 5 stars	3.3	2.0	4.2	2.1	0.8	1.9
DCGO DocGo	2.2784 of 5 stars	3.3	2.0	0.0	1.9	2.5	0.6
PNTG The Pennant Group	3.0816 of 5 stars	2.3	4.0	0.0	3.2	2.5	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AVAH Aveanna Healthcare	2.00	Hold	$5.13	5.24% Upside
CDNA CareDx	2.67	Moderate Buy	$30.33	60.07% Upside
DCGO DocGo	2.50	Moderate Buy	$3.56	110.65% Upside
PNTG The Pennant Group	2.60	Moderate Buy	$34.60	22.61% Upside

Current Analyst Ratings Breakdown

Latest DCGO, AVAH, CDNA, and PNTG Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/10/2025	PNTG The Pennant Group	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$35.00
6/3/2025	PNTG The Pennant Group	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$30.00 ➝ $31.00
5/12/2025	DCGO DocGo	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$5.00 ➝ $1.45
5/12/2025	PNTG The Pennant Group	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$28.00 ➝ $32.00
5/9/2025	AVAH Aveanna Healthcare	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Sell ➝ Sell	$4.50 ➝ $5.00
5/9/2025	DCGO DocGo	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$4.00 ➝ $3.00
5/9/2025	DCGO DocGo	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral
5/5/2025	CDNA CareDx	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$40.00 ➝ $40.00
5/5/2025	CDNA CareDx	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$25.00 ➝ $25.00
4/17/2025	CDNA CareDx	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$34.00 ➝ $26.00
4/11/2025	AVAH Aveanna Healthcare	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$6.00 ➝ $5.50

(Data available from 6/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AVAH Aveanna Healthcare	$2.02B	0.47	$0.17 per share	28.79	($0.64) per share	-7.61
CDNA CareDx	$333.79M	3.16	$1.35 per share	14.00	$7.06 per share	2.68
DCGO DocGo	$616.55M	0.28	$0.45 per share	3.76	$3.09 per share	0.55
PNTG The Pennant Group	$695.24M	1.40	$0.94 per share	30.13	$9.08 per share	3.11

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AVAH Aveanna Healthcare	-$10.93M	$0.02	243.50	∞	N/A	0.26%	-15.16%	1.14%	8/6/2025 (Estimated)
CDNA CareDx	$52.55M	$1.15	16.48	N/A	N/A	19.79%	21.16%	14.25%	7/30/2025 (Estimated)
DCGO DocGo	$19.99M	-$0.02	N/A	21.13	N/A	-0.12%	2.52%	1.70%	8/6/2025 (Estimated)
PNTG The Pennant Group	$22.56M	$0.76	37.13	32.07	2.36	3.40%	10.73%	4.00%	8/5/2025 (Estimated)

Latest DCGO, AVAH, CDNA, and PNTG Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
5/8/2025	Q1 2025	DCGO DocGo	-$0.01	-$0.09	-$0.08	-$0.09	$104.25 million	$96.03 million
4/30/2025	Q1 2025	CDNA CareDx	$0.06	$0.09	+$0.03	-$0.19	$84.56 million	$84.69 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AVAH Aveanna Healthcare	N/A	N/A	N/A	N/A	N/A
CDNA CareDx	N/A	N/A	N/A	N/A	N/A
DCGO DocGo	N/A	N/A	N/A	N/A	N/A
PNTG The Pennant Group	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AVAH Aveanna Healthcare	N/A	1.05	1.05
CDNA CareDx	N/A	4.11	3.84
DCGO DocGo	N/A	2.44	2.44
PNTG The Pennant Group	0.81	1.41	1.41

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AVAH Aveanna Healthcare	87.96%
CDNA CareDx	N/A
DCGO DocGo	56.44%
PNTG The Pennant Group	85.88%

Insider Ownership

Company	Insider Ownership
AVAH Aveanna Healthcare	7.00%
CDNA CareDx	4.40%
DCGO DocGo	2.70%
PNTG The Pennant Group	5.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AVAH Aveanna Healthcare	33,500	195.09 million	181.44 million	Optionable
CDNA CareDx	740	55.68 million	53.23 million	Optionable
DCGO DocGo	4,407	101.98 million	99.23 million	Optionable
PNTG The Pennant Group	7,000	34.47 million	32.61 million	Optionable

DCGO, AVAH, CDNA, and PNTG Headlines

Recent News About These Companies

Riverbridge Partners LLC Sells 81,583 Shares of The Pennant Group, Inc. (NASDAQ:PNTG)

June 20, 2025 | marketbeat.com

Stephens Reaffirms "Overweight" Rating for The Pennant Group (NASDAQ:PNTG)

June 10, 2025 | marketbeat.com

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 14,020 Shares of The Pennant Group, Inc. (NASDAQ:PNTG)

June 8, 2025 | marketbeat.com

Squarepoint Ops LLC Takes Position in The Pennant Group, Inc. (NASDAQ:PNTG)

June 6, 2025 | marketbeat.com

Mackenzie Financial Corp Invests $475,000 in The Pennant Group, Inc. (NASDAQ:PNTG)

June 4, 2025 | marketbeat.com

Wells Fargo & Company Issues Positive Forecast for The Pennant Group (NASDAQ:PNTG) Stock Price

June 3, 2025 | marketbeat.com

ProShare Advisors LLC Buys New Shares in The Pennant Group, Inc. (NASDAQ:PNTG)

June 1, 2025 | marketbeat.com

The Pennant Group, Inc. (NASDAQ:PNTG) Shares Purchased by Bank of America Corp DE

June 1, 2025 | marketbeat.com

Is There Now An Opportunity In The Pennant Group, Inc. (NASDAQ:PNTG)?

May 30, 2025 | finance.yahoo.com

Voloridge Investment Management LLC Makes New Investment in The Pennant Group, Inc. (NASDAQ:PNTG)

May 30, 2025 | marketbeat.com

Two Sigma Investments LP Has $4.11 Million Holdings in The Pennant Group, Inc. (NASDAQ:PNTG)

May 30, 2025 | marketbeat.com

Millennium Management LLC Boosts Stock Position in The Pennant Group, Inc. (NASDAQ:PNTG)

May 30, 2025 | marketbeat.com

Two Sigma Advisers LP Acquires 77,900 Shares of The Pennant Group, Inc. (NASDAQ:PNTG)

May 28, 2025 | marketbeat.com

Nuveen Asset Management LLC Increases Holdings in The Pennant Group, Inc. (NASDAQ:PNTG)

May 28, 2025 | marketbeat.com

Joanne Stringfield Sells 5,000 Shares of The Pennant Group, Inc. (NASDAQ:PNTG) Stock

May 24, 2025 | insidertrades.com

PharVision Advisers LLC Invests $304,000 in The Pennant Group, Inc. (NASDAQ:PNTG)

May 24, 2025 | marketbeat.com

Pennant Group holds annual meeting, elects directors

May 21, 2025 | investing.com

PNTG Q1 Earnings Call: Acquisition Momentum and Organic Growth Drive Outperformance

May 20, 2025 | finance.yahoo.com

Pennant Group appoints new board director

May 18, 2025 | investing.com

Additional Considerations Required While Assessing Pennant Group's (NASDAQ:PNTG) Strong Earnings

May 16, 2025 | finance.yahoo.com

The Pennant Group, Inc. Announces Appointment of Suzanne D. Snapper to Board of Directors

May 16, 2025 | quiverquant.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

DCGO, AVAH, CDNA, and PNTG Company Descriptions

Aveanna Healthcare NASDAQ:AVAH

$4.87 +0.15 (+3.18%)

Closing price 06/23/2025 04:00 PM Eastern

Extended Trading

$4.86 0.00 (-0.10%)

As of 06/23/2025 04:10 PM Eastern

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

CareDx NASDAQ:CDNA

$18.95 -0.09 (-0.47%)

Closing price 06/23/2025 04:00 PM Eastern

Extended Trading

$19.00 +0.05 (+0.26%)

As of 06/23/2025 07:56 PM Eastern

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.

DocGo NASDAQ:DCGO

$1.69 +0.10 (+6.29%)

Closing price 06/23/2025 04:00 PM Eastern

Extended Trading

$1.69 0.00 (0.00%)

As of 06/23/2025 05:56 PM Eastern

DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.

The Pennant Group NASDAQ:PNTG

$28.22 +0.44 (+1.58%)

Closing price 06/23/2025 04:00 PM Eastern

Extended Trading

$28.20 -0.02 (-0.07%)

As of 06/23/2025 04:20 PM Eastern

The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time